NAMS Competitors & Alternatives
Compare NewAmsterdam Pharma Company N.V. Ordinary Shares with similar stocks in the same industry
Biotechnology
NAMS
Main Stock$35.74
Tradestie Score
61
Market Cap
$3.31B
Revenue Growth
-1.0%
Analyst Upside
+40.1%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARWR
Arrowhead Research Corporation
|
$75.54
|
$4.84B | - | 54 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$102.01
|
$3.98B | - | 56 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$37.09
|
$3.92B | - | 53 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$80.61
|
$3.91B | - | 55 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$19.10
|
$3.83B | - | 51 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$20.66
|
$3.68B | - | 47 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$100.67
|
$3.67B | - | 56 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$8.46
|
$3.59B | 12.6 | 54 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$21.32
|
$3.58B | 9.3 | 58 | Compare |
More NAMS Analysis
Data updated: May 21, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry